METHOD FOR EARLY PREDICTION OF MISCARRIAGE ASSOCIATED WITH REACTIVATION OF CYTOMEGALOVIRUS INFECTION Russian patent published in 2023 - IPC G01N33/68 G01N33/569 G01N33/573 

Abstract RU 2787451 C1

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely obstetrics, gynecology and pathological physiology, and can be used for early prediction of miscarriage associated with reactivation of cytomegalovirus infection. The content of interleukin 1ß (IL-1ß) in pg/ml and the concentration of nuclear factor kappa-B (NF-kb) in pg/ml are determined in serum by enzyme immunoassay in women. The level of cyclooxygenase-2 (COX-2) in ng/ml is determined in the lysate of mononuclear cells. Then the risk of developing the threat of miscarriage is predicted using the PI prognostic index calculated by the formula: PI=-280.024+(0.260×IL-1ß)-(4,271×NF-kb)+(14.031×COX-2), where PI is a prognostic index resulting from a discriminant function whose boundary value is 59.621. With PI equal to or greater than the boundary value, the threat of miscarriage associated with reactivation of cytomegalovirus infection in the early stages is predicted. When PI is less than the boundary value, it is predicted that there is no threat of miscarriage associated with reactivation of cytomegalovirus infection in the early stages.

EFFECT: method makes it possible to increase the accuracy of predicting miscarriage during early pregnancy associated with reactivation of cytomegalovirus infection by determining the content of IL-1ß, NF-kb in the blood, as well as the content of COX-2 cells in the lysate of mononuclear cells.

1 cl, 2 ex

Similar patents RU2787451C1

Title Year Author Number
METHOD OF EARLY PREDICTION OF MISCARRIAGE BY ASSESSING INTERLEUKIN 1Β AND PROSTAGLANDIN E2 IN THE BLOOD SERUM OF PREGNANT WOMEN WITH EXACERBATION OF CYTOMEGALOVIRUS INFECTION 2023
  • Ishutina Nataliia Aleksandrovna
  • Andrievskaia Irina Anatolevna
  • Dovzhikova Inna Viktorovna
  • Dorofienko Nikolai Nikolaevich
  • Kutepova Olga Leonidovna
  • Prikhodko Nikolai Gennadevich
RU2804278C1
METHOD OF PREDICTING MISCARRIAGE IN THE FIRST TRIMESTER BY ASSESSING CYCLOOXYGENASE 2 AND PROSTAGLANDIN E2 IN THE PERIPHERAL BLOOD OF PREGNANT WOMEN DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION 2023
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
  • Dovzhikova Inna Viktorovna
  • Dorofienko Nikolai Nikolaevich
  • Kutepova Olga Leonidovna
RU2800080C1
METHOD FOR PREDICTING THE THREAT OF MISCARRIAGE DURING REACTIVATION OF LATENT CYTOMEGALOVIRUS INFECTION BY DETERMINING ESTRADIOL AND ESTROGEN RECEPTOR ALPHA IN BLOOD SERUM 2021
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
  • Dovzhikova Inna Viktorovna
  • Petrova Kseniia Konstantinovna
  • Prikhodko Nikolai Gennadevich
RU2762485C1
METHOD FOR PREDICTING THREAT OF EARLY TERMINATION OF PREGNANCY DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION BY DETERMINING PLACENTAL GROWTH FACTOR AND ARACHIDONIC ACID IN BLOOD SERUM 2021
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
  • Petrova Kseniia Konstantinovna
  • Prikhodko Nikolai Gennadevich
RU2751965C1
METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN SECOND HALF OF PREGNANCY IN SEROPOSITIVE BY CYTOMEGALOVIRUS WOMEN 2020
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
RU2724395C1
METHOD OF PREDICTING MISCARRIAGE BY ASSESSING VASCULAR ENDOTHELIAL GROWTH FACTOR AND PROSTAGLANDIN F2Α IN THE PERIPHERAL BLOOD OF PREGNANT WOMEN DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION IN THE FIRST TRIMESTER 2023
  • Ishutina Nataliia Aleksandrovna
  • Andrievskaia Irina Anatolevna
  • Dovzhikova Inna Viktorovna
  • Dorofienko Nikolai Nikolaevich
RU2800311C1
METHOD FOR PREDICTION OF THREATENED MISCARRIAGE BY DETERMINING BLOOD SERUM OF 8-ISOPROSTANE AND 15-HYDROXYEICOSATETRAENOIC ACID IN WOMEN WITH COVID-19 IN THE FIRST TRIMESTER 2024
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
  • Dovzhikova Inna Viktorovna
  • Kutepova Olga Leonidovna
RU2821133C1
METHOD FOR PREDICTING MISCARRIAGE IN THE EARLY STAGES BY DETERMINING VASCULAR ENDOTHELIAL GROWTH FACTOR AND HYPOXIA INDUCIBLE FACTOR 1Α IN THE BLOOD SERUM OF PREGNANT WOMEN WITH CYTOMEGALOVIRUS INFECTION 2022
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
  • Dorofienko Nikolai Nikolaevich
  • Dovzhikova Inna Viktorovna
RU2782110C1
METHOD FOR PREDICTION OF DEVELOPMENT OF PREECLAMPSIA IN WOMEN WITH REACTIVATION OF LATENT CYTOMEGALOVIRUS INFECTION IN THE SECOND TRIMESTER OF PREGNANCY 2021
  • Andrievskaia Irina Anatolevna
  • Ishutina Nataliia Aleksandrovna
  • Dovzhikova Inna Viktorovna
  • Gorikov Igor Nikolaevich
  • Petrova Kseniia Konstantinovna
  • Prikhodko Nikolai Gennadevich
RU2765541C1
METHOD FOR PREDICTING THREAT OF EARLY TERMINATION OF PREGNANCY DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION BY DETERMINING Α-TOCOPHEROL AND W-3 POLYUNSATURATED FATTY ACIDS IN BLOOD SERUM 2021
  • Ishutina Nataliia Aleksandrovna
  • Andrievskaia Irina Anatolevna
  • Dovzhikova Inna Viktorovna
  • Dorofienko Nikolai Nikolaevich
RU2751650C1

RU 2 787 451 C1

Authors

Andrievskaia Irina Anatolevna

Ishutina Nataliia Aleksandrovna

Dovzhikova Inna Viktorovna

Dorofienko Nikolai Nikolaevich

Dates

2023-01-09Published

2022-03-21Filed